Korean J Obstet Gynecol.  2000 Jan;43(1):22-25.

Intravenous immunoglobulin for patients with repeated failure of in vitro fertilization-embryo transfer

Abstract


OBJECTIVE
The implantation failure after embryo-transfer (ET) is a major continuing problem in in vitro fertilization (IVF). This study was undertaken to determine the effectiveness of intravenous immunoglobulin for treatment of individuals experiencing repeated unexplained in vitro fertilization-embryo transfer (IVF-ET) failure.
METHODS
A total of nine consecutive infertile patients who failed to become pregnant after previous IVF-ET replacing at least three or more normal developed embryos each were included in our study. During the subsequent new IVF-ET cycle, each women received intravenous immunoglobulin 500mg/kg before the embryo transfer.
RESULTS
Only one implantation occurred. There were no remarkable side effects. A specific effect of intravenous immunoglobulin for patients with repeated IVF-ET failure could not be demonstrated.
CONCLUSION
High-dose intravenous immunoglobulin may not be useful for patients with repeated failure of embryo transfer.

Keyword

Intravenous immunoglobulin; IVF-ET failure

MeSH Terms

Embryo Transfer
Embryonic Structures
Female
Fertilization in Vitro
Humans
Immunoglobulins*
Immunoglobulins
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr